Cva Family Office, LLC Sarepta Therapeutics, Inc. Transaction History
Cva Family Office, LLC
- $634 Million
- Q1 2025
A detailed history of Cva Family Office, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Cva Family Office, LLC holds 6 shares of SRPT stock, worth $381. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6Holding current value
$381% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SRPT
# of Institutions
510Shares Held
85.2MCall Options Held
1.5MPut Options Held
1.26M-
Black Rock Inc. New York, NY10.3MShares$657 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$575 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$554 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$276 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$259 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $5.57B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...